BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 10311749)

  • 1. Diagnosis related groups and the price of cost containment.
    Sophy KG
    J Contemp Health Law Policy; 1986; 2():305-26. PubMed ID: 10311749
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospective payment: a new direction for hospitals.
    Rev Fed Am Hosp; 1983; 16(2):24-6, 29-30, 33-4. PubMed ID: 10309843
    [No Abstract]   [Full Text] [Related]  

  • 3. Hospital participation in alternative payment: developing a DRG-based system.
    Ellstein C; Wheeler JR
    Top Health Care Financ; 1986; 13(2):27-37. PubMed ID: 3101228
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of hospital financial data.
    Selke G
    Osteopath Hosp Leadersh; 1986 Jun; 30(4):16-8. PubMed ID: 10311633
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential responses to the Medicare pricing mechanism.
    Broyles RW; Rosko MD
    Hosp Health Serv Adm; 1986; 31(3):70-82. PubMed ID: 10311507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional responses to prospective payment based on diagnosis-related groups. Implications for cost, quality, and access.
    Stern RS; Epstein AM
    N Engl J Med; 1985 Mar; 312(10):621-7. PubMed ID: 3919294
    [No Abstract]   [Full Text] [Related]  

  • 7. DRGs: a new era for health care.
    Shaffer FA
    Nurs Clin North Am; 1988 Sep; 23(3):453-63. PubMed ID: 3138663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A positive first step: prospective payment by DRG.
    Averill RF; Kalison MJ
    Healthc Financ Manage; 1983 Feb; 37(2):12-4, 18-22. PubMed ID: 10315273
    [No Abstract]   [Full Text] [Related]  

  • 9. DRGs being adopted by other insurers.
    Wilson CN
    Hosp Pharm; 1990 May; 25(5):482-3. PubMed ID: 10113208
    [No Abstract]   [Full Text] [Related]  

  • 10. Does severity of illness make a difference in prospective payment?
    Horn SD
    Healthc Financ Manage; 1983 May; 37(5):49-53. PubMed ID: 10315319
    [No Abstract]   [Full Text] [Related]  

  • 11. DRG winners and losers affect profits under prospective payment.
    Mendenhall S
    Healthc Financ Manage; 1985 Jul; 39(7):62-8. PubMed ID: 10311154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital financial reimbursement reductions under Medicare.
    Wilson CN
    Hosp Pharm; 1985 Dec; 20(12):926-8. PubMed ID: 10311348
    [No Abstract]   [Full Text] [Related]  

  • 13. Managers wanted. Case mix reimbursement demands managers, not facilitators.
    Mannisto M
    Hospitals; 1983 Mar; 57(6):91-3. PubMed ID: 6402443
    [No Abstract]   [Full Text] [Related]  

  • 14. PPS and quality care: can they coexist?
    Vladeck BC
    Healthspan; 1986 Jan; 3(1):15-8. PubMed ID: 10311449
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-per-case reimbursement: a challenge to hospital management.
    Bassett JG
    Top Health Rec Manage; 1984 Mar; 4(3):1-9. PubMed ID: 10310487
    [No Abstract]   [Full Text] [Related]  

  • 16. Medicare prospective payment for hospitals.
    Pitcher V
    Bull Am Coll Surg; 1983 Dec; 68(12):19-20, 38. PubMed ID: 10310302
    [No Abstract]   [Full Text] [Related]  

  • 17. HCFA pilot project may bolster hospital-physician collaboration.
    Koska MT
    Hospitals; 1991 Apr; 65(8):49-50, 52. PubMed ID: 1901295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare payment and DRGs.
    Lubaway WJ
    Mich Hosp; 1983 Oct; 19(10):19-21. PubMed ID: 10310398
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective pricing system, DRGs, and their impact on health care operations.
    Mehra S
    J Health Hum Resour Adm; 1986; 9(2):232-45. PubMed ID: 10312032
    [No Abstract]   [Full Text] [Related]  

  • 20. The fact book on prospective payment. Health industry Manufacturers Association.
    Med Prod Sales; 1983 Jun; 14(6):68-71, 94-103. PubMed ID: 10310091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.